🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareGLP-1 receptor expression in cardiac tissue — cardioprotection mechanisms Page 3

GLP-1 receptor expression in cardiac tissue — cardioprotection mechanisms

Dr.CardioMD Sat, May 30, 2026 at 10:12 AM 20 replies 580 viewsPage 3 of 4
tampaLisa73
Member
312
1,456
Oct 2024
Tampa, FL
May 31, 2026 at 3:12 AM#11
GenomicsKate said:
Receptor pharmacology relevant to the pharmacology: semaglutide is a GLP-1R agonist with a C-18 fatty acid chain that enables albumin binding (>99%),…

This is exactly what I could not find anywhere else.

9 7RunnerRach, TrialNerd_Beth, HPLC_Greg and 6 others
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
May 31, 2026 at 2:42 PM#12

From the other side of the consultation, briefly. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

10 8Dr.PathRoch, mona_PHX, andrew_nyc and 7 others
Reply Quote Save Share Report
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Jun 1, 2026 at 2:12 AM#13
VanRx_Mike said:
Semaglutide structural biology relevant to the pharmacology: semaglutide is a 31-amino acid peptide with 94% homology to native GLP-1(7-36).

This is where I part company with the consensus forming above. Pushing back on the anecdote-stacking. Twenty people reporting the same thing is twenty samples from the same self-selected pool, not twenty independent confirmations.

11 9CanadaChris, ZaraB_AL, JakeSmashed95 and 8 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Jun 1, 2026 at 1:42 PM#14

Adding the numbers, since they settle part of this. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

Last edited: Jun 1, 2026 at 3:42 PM
12 10KarenAZ_mom, zoe_NC, Dr.ObesityLA and 9 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jun 2, 2026 at 1:13 AM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Carry on.

13 11PurityPaulOR, MaxMetOK, MounjBrad and 10 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register